JAMA Oncology : Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

JAMA Network
30/01/2025 11 min
JAMA Oncology : Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Listen "JAMA Oncology : Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy

More episodes of the podcast JAMA Network

JAMA Ophthalmology : Foundation Models vs Physicians in Ophthalmological Questions 13/11/2025
JAMA Otolaryngology–Head & Neck Surgery : Evaluation of Practice Patterns for 6-Sinus Balloon Sinus Dilation 13/11/2025
JAMA Dermatology : Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis 12/11/2025
JAMA Internal Medicine : Lifestyle Intervention for Sustained Remission of Metabolic Syndrome 09/11/2025
JAMA Oncology : Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality 30/10/2025
JAMA Ophthalmology : Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy 30/10/2025
JAMA Psychiatry : Serial Ketamine Infusions as an Adjunctive Therapy to Inpatient Care for Depression 22/10/2025
JAMA Surgery : 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions 22/10/2025
JAMA Ophthalmology : Diabetes in the Donor and Descemet Membrane Endothelial Keratoplasty Success at 1 Year 17/10/2025
JAMA Otolaryngology–Head & Neck Surgery : The JAMA Otolaryngology-Head & Neck Surgery Editorial Fellowship Experience 16/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA